By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk's shares tumbled as much as 20% ...
Chief Executive Officer Mike Doustdar warned, “People should expect that it goes down before it comes back up,” citing pressure from significantly lower US pricing on its blockbuster weight-loss drug ...
Shares in the Danish pharmaceuticals group Novo Nordisk plunged Wednesday after the maker of Ozempic and Wegovy anti-obesity ...
Dow Jones Top Company Headlines at 5 AM ET: Wegovy Maker Novo Nordisk's Shares Slump After Guidance Disappoints | UBS ... The stock tumbled 19% at the opening bell in Copenhagen after its outlook for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results